Dexrazoxane and the ASCO guidelines for the use of chemotherapy and radiotherapy protectants: A critique [2] (multiple letters)

Journal of Clinical Oncology

Volumn 18, Issue 9, 2000, Pages 2004-2006

  Hellmann, K ^a   Hensley, M L ^a   Schuchter, L M ^a   Winer, E P ^a   Meropol, N J ^a   Pfister, D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RAZOXANE;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; DRUG EFFECT; HEART PROTECTION; HUMAN; LETTER; PRACTICE GUIDELINE; PRIORITY JOURNAL;

EID: 0034060355     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.2000.18.9.2004     Document Type: Letter

References (0)